SCHEMBL22625307

SCHEMBL22625307

C=CC(=O)OC1CCC(Oc2ccc3cc(-c4ccc(CCCCC)cc4CC)c(=O)oc3c2)C1C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.39
MAOB P27338 4/20 0.34
MAOA P21397 3/20 0.34
KDM4E B2RXH2 4/20 0.32
HPGD P15428 3/20 0.32
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
GLA P06280 3/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SLC10A1 Q14973 1/20 0.32
PTPN7 P35236 1/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
MAPT P10636 2/20 0.32
ALDH1A1 P00352 2/20 0.32
GAA P10253 2/20 0.32
PKM P14618 1/20 0.32
MAPK1 P28482 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625413 0.92 THRB (0.38) THRBMAOBMAOAKDM4EHPGD
SCHEMBL22624951 0.91 KDM4E (0.38) THRBMAOBMAOAKDM4EHPGD
SCHEMBL21735368 0.91 THRB (0.40) THRBS1PR1S1PR3ACHE
SCHEMBL22625061 0.91 THRB (0.37) THRBMAOBMAOAKDM4EHPGD
SCHEMBL25848254 0.90 THRB (0.41) THRBMAOBMAOAKDM4EHPGD
SCHEMBL22624927 0.90 NPC1 (0.34) MAOBMAOAKDM4EHPGDNPC1
SCHEMBL25855079 0.90 KDM4E (0.36) MAOBMAOAKDM4EHPGDNPC1
SCHEMBL22625366 0.86 MAOB (0.33) MAOBMAOAKDM4EHPGDNPC1
SCHEMBL22624990 0.86 RAB9A (0.39) MAOBMAOAKDM4EHPGDNPC1
SCHEMBL22625077 0.86 MAOB (0.34) MAOBMAOAKDM4EHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed
EP-3583102-B1 HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2020-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 THRB 3289/4885MAOB 3207/4885MAOA 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.